Novelix Pharmaceuticals Limited (BOM:536565)

India · Delayed Price · Currency is INR

66.23

-3.77 (-5.39%)

At close: Oct 5, 2026

Market Cap	1.97B +227.3%
Revenue (ttm)	1.47B +180.4%
Net Income	36.29M +565.3%
EPS	1.50 +198.8%
Shares Out	28.47M
PE Ratio	46.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,859
Open	70.00
Previous Close	70.00
Day's Range	65.00 - 73.97
52-Week Range	38.00 - 92.00
Beta	0.26
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited manufactures and trades pharmaceutical bulk drugs and related products in activities related to healthcare research, analytics, and technology in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1994

Employees 32

Stock Exchange Bombay Stock Exchange

Ticker Symbol 536565

Full Company Profile

Financial Performance

In fiscal year 2026, Novelix Pharmaceuticals's revenue was 1.32 billion, an increase of 330.60% compared to the previous year's 307.33 million. Earnings were 25.57 million, an increase of 2925.56%.

Financial Statements